Merck tries new approach to treat insomnia bi13281454 Merck (NYSE: MRK) to file a new drug application the U.S. Food and Drug Administration following successful Phase III clinical trial results. The Whitehouse Station, New Jersey company?s drug, Suvorexant, generated positive results clinical trials that sought to prove the efficacy of the drug. Peter S. Kim, president of Merck Research Laboratories said: []..

Merck to pay millions to settle lawsuits Canada bi13281454 titan Merck and Co. Inc. has agreed to compensate more than a thousand Canadians who blame the company's pain medication for increasing risk of cardiac complications

Merck to sponsor Tagore award bi13281454 Kolkata, Jan 17 : German company Merck sponsor the Merck-Tagore Cultural award to honour the work and life of the first non-European Nobel laureate Rabindranath Tagore

Merck Frosst loses information-protection appeal bi13281454 giant Merck Frosst, lost legal battle Friday to keep what considers to be trade secrets exempt from Canada's access-to-information legislation, expressed "disappointment" but said abide by the Supreme Court of Canada's decision

Merck revisits Tagore abode , institutes Merck-Tagore award bi13281454 Santiniketan, Jan 20 : Merck, the Germany based and chemical company, announced the institution of the Merck-Tagore Award to recognise special contributions for promoting cultural exchange between India and Germany

Frost & Sullivan Honours Merck Serono for Its Achievements the Treatment o bi13281454 LONDON-- - Based on recent analysis of the infertility therapeutics market, Frost & Sullivan recognizes Merck Serono, the division of Merck KGaA, Darmstadt, Germany, the 2011 Europe ..

Merck & Co Inc. Earnings: Margins Expand For Fifth Straight Quarter bi13281454 Here's a closer look at the company's latest earnings release..

Merck beats consensus on income but not revenue bi13281454 US giant Merck presented fourth quarter results morning and revealed adjusted net income that topped expectations

Merck to pay at least $21.8 million to settle Vioxx lawsuits Canada bi13281454 A titan has agreed to compensate more than a thousand Canadians who blame the company's pain medication for increasing risk of cardiac complications

Merck Beats on EPS, Guides In-Line bi13281454 The company expects earnings the range of $3.75 - $3.85 per share. The Zacks Consensus Estimate currently stands towards the higher end of the guidance range at $3.83

Frost & Sullivan Honours Merck Serono for Its Achievements the Treatment o bi13281454 LONDON-- - Based on recent analysis of the infertility therapeutics market, Frost & Sullivan recognizes Merck Serono, the division of Merck KGaA, Darmstadt, Germany, the 2011 Europe ..

Merck Frosst loses information-protection appeal bi13281454 giant Merck Frosst, lost legal battle Friday to keep what considers to be trade secrets exempt from Canada's access-to-information legislation, expressed "disappointment" but said abide by the Supreme Court of Canada's decision

Merck to pay up to CAN$36.8 mn to settle Vioxx suit bi13281454 giant Merck said Thursday has agreed to pay up to CAN$36.8 million (US$36.3 million) to resolve all suits brought against Canada over former hit painkiller Vioxx

Ps2 Backup Software - Home